MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered Advanced Solid Tumors.

Autor: Sweeney, Christopher J., Hainsworth, John D., Bose, Ron, Burris, Howard A., Kurzrock, Razelle, Swanton, Charles, Friedman, Claire F., Spigel, David R., Szado, Tania, Schulze, Katja, Price, Richard, Malato, Julia, Lo, Amy A., Levy, Jonathan, Wang, Yong, Yu, Wei, Meric-Bernstam, Funda
Zdroj: Journal of Clinical Oncology; 1/20/2024, Vol. 42 Issue 3, p258-265, 10p
Databáze: Supplemental Index